Company Filing History:
Years Active: 1992-1998
Title: Innovations of Choon W Lee: A Pioneer in Proteoglycan Research
Introduction
Choon W Lee, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology through his innovative research and patents. With a total of three patents to his name, he has become a notable figure in the development of bioactive compounds, especially in relation to antitumor immunity.
Latest Patents
Lee's most recent patent, Ganoderma lucidum KCCM 10045, relates to a strain of Ganoderma lucidum, specifically IY 009. This strain produces a potent proteoglycan, referred to as G009, known for its antitumoral and immunostimulating effects. The patent details the composition of this proteoglycan, which includes saccharide components such as beta-glucose, alpha-glucose, galactose, alpha-mannose, and fructose. It also consists of protein components like glycine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrosine, proline, phenylalanine, and methionine. The strain, Ganoderma lucidum IY 009, is officially deposited under the accession number KCCM 10045, marking a significant advancement in biotechnology.
Career Highlights
Throughout his career, Choon W Lee has been associated with several prominent companies in the pharmaceutical sector. Notably, he has worked with Il Yang Pharmaceutical Company, Ltd., and Dong-a Pharm. Co., Ltd., where he has applied his research to develop valuable products that contribute to health and wellness.
Collaborations
Lee's innovative journey has been further enriched by collaborations with talented colleagues such as Kwon Haeng Lee and Hoon Chung. Together, they have pushed the boundaries of research and development, leading to breakthroughs in pharmacology and biotechnology.
Conclusion
Choon W Lee's unwavering commitment to innovation and research has not only led to the creation of valuable patents but also contributed significantly to the fight against cancer through his discovery of proteoglycans. His work exemplifies the spirit of invention and the potential for biotechnological advancements to improve human health.